TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9038390

Group type: EXPERIMENTAL
Intervention: Neuroendocrine differentiation identified using Churukian‐Schenk and Garvey silver impregnations.
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Neuroendocrine cells identified in 15 cases, 6 with malignant pattern.
Number of subjects: 68
Study: 2065499

Group type: EXPERIMENTAL
Intervention: Sodium fluoride (50 mg/day p.o.)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Vitamin D (0.5 micrograms/day of 1 alpha (OH)2D3)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control groups (not specified)
Number of subjects: 21
Study: 6353831

Group type: EXPERIMENTAL
Intervention: FK 33-824 (0.5 mg im injection)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 8
Study: 30650445

Group type: EXPERIMENTAL
Intervention: Macrophage colony-stimulating factor (M-CSF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Granulocyte-macrophage colony-stimulating factor (GM-CSF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clotted plasma (embedding haemophilia monocytes)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Leptin added to a monocyte cell line
Number of subjects: 0
Study: 28420909

Group type: EXPERIMENTAL
Intervention: Intrauterine lidocaine infusion
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Paracervical block with lidocaine
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Intravenous tenoxicam
Number of subjects: 232

Group type: COMPARATOR
Intervention: Control (4ml intravenous normal saline)
Number of subjects: 232
Study: 25726411

Group type: EXPERIMENTAL
Intervention: Regadenoson CTP
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Coronary CT angiography (CTA)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Regadenoson SPECT
Number of subjects: 124
Study: 24315520

Group type: EXPERIMENTAL
Intervention: Two-layer compression hosiery
Number of subjects: 457

Group type: COMPARATOR
Intervention: Four-layer bandage
Number of subjects: 457

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 457
Study: 23882146

Group type: EXPERIMENTAL
Intervention: 1,3-dimethylamylamine supplement
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 19159854

Group type: EXPERIMENTAL
Intervention: CAPSID (computerized angioplasty pressure sensor and inflator device)
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: CAPSID (computerized angioplasty pressure sensor and inflator device) with stenting
Number of subjects: 234

Group type: COMPARATOR
Intervention: Standard balloon inflation (plain old balloon angioplasty)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Standard balloon inflation (plain old balloon angioplasty) with stenting
Number of subjects: 234
Study: 17046034

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (5 g of creatine monohydrate, four times a day for 7 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Creatine supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Creatine supplementation and Placebo
Number of subjects: 0
Study: 15899959

Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 7522

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7522
Study: 11979153

Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine at a dose of 0.1 mmol/kg
Number of subjects: 82

Group type: COMPARATOR
Intervention: Gadodiamide at a dose of 0.1 mmol/kg
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine at doses of 0.05 and 0.15 mmol/kg and 0.1 and 0.2 mmol/kg
Number of subjects: 82

Group type: COMPARATOR
Intervention: Gadodiamide at doses of 0.1 and 0.3 mmol/kg
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: All groups (Gadobenate dimeglumine and Gadodiamide)
Number of subjects: 82
Study: 9718588

Group type: EXPERIMENTAL
Intervention: MDMA (1.7 mg/kg)
Number of subjects: 13
Study: 8573552

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 0
Study: 2218041

Group type: EXPERIMENTAL
Intervention: PLAX prebrushing rinse
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 76224

Group type: EXPERIMENTAL
Intervention: Methotrexate alone
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Five-drug regimen
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Adriamycin, T.I.C.-mustard, and methotrexate
Number of subjects: 75

Group type: COMPARATOR
Intervention: Methotrexate
Number of subjects: 75

Group type: COMPARATOR
Intervention: Combination chemotherapy
Number of subjects: 75
Study: 31586999

Group type: EXPERIMENTAL
Intervention: Topical adapalene 0.3%/benzoyl peroxide (A‐BPO) 2.5% with explicative leaflet (G1)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Topical adapalene 0.3%/benzoyl peroxide (A‐BPO) 2.5% with SMS reminders (G2)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Topical adapalene 0.3%/benzoyl peroxide (A‐BPO) 2.5% with standard instructions (G3)
Number of subjects: 126
Study: 27694498

Group type: EXPERIMENTAL
Intervention: Specialist physiotherapy intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Treatment as usual control
Number of subjects: 60
Study: 25041252

Group type: EXPERIMENTAL
Intervention: Platform-switching implants placed 1 mm below bone level (test group)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Implants placed at bone level (control group)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Both groups (test and control)
Number of subjects: 56
Study: 22889358

Group type: EXPERIMENTAL
Intervention: Surgery with gentamicin-collagen (GS+, n = 52)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Surgery without gentamicin-collagen (GS-, n = 50)
Number of subjects: 102
Study: 21244615

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 105
Study: 19232157

Group type: EXPERIMENTAL
Intervention: Below knee cast
Number of subjects: 584

Group type: EXPERIMENTAL
Intervention: Aircast ankle brace
Number of subjects: 584

Group type: EXPERIMENTAL
Intervention: Bledsoe boot
Number of subjects: 584

Group type: COMPARATOR
Intervention: Tubular bandage
Number of subjects: 584
Study: 16448890

Group type: EXPERIMENTAL
Intervention: Caffeine (4 mg/kg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 14
Study: 15065530

Group type: EXPERIMENTAL
Intervention: Rabeprazole 20 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg
Number of subjects: 16
Study: 11137267

Group type: EXPERIMENTAL
Intervention: 1.0 mg doses at 3-day intervals
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 9270502

Group type: EXPERIMENTAL
Intervention: SPF 15 sunscreen with high UVA protection
Number of subjects: 160

Group type: COMPARATOR
Intervention: No sunscreen (control group)
Number of subjects: 160
Study: 1388115

Group type: EXPERIMENTAL
Intervention: Amlodipine (5-10 mg/day)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Nifedipine R (20-40 mg b.i.d.)
Number of subjects: 29
Study: 3890436

Group type: EXPERIMENTAL
Intervention: Metronidazole (1 g)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Doxycycline (0.2 g)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 74

Group type: COMPARATOR
Intervention: Doxycycline
Number of subjects: 74
Study: 29153463

Group type: EXPERIMENTAL
Intervention: Hypofractionated LNRT (2.67-3.3 Gy)
Number of subjects: 864

Group type: EXPERIMENTAL
Intervention: Hypofractionated LNRT (3.3 Gy for 13 fractions)
Number of subjects: 864

Group type: COMPARATOR
Intervention: Control group (2.0 Gy fractions)
Number of subjects: 864
Study: 26135682

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 124

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 124
Study: 24861959

Group type: EXPERIMENTAL
Intervention: Counselor-delivered intervention
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Web-based intervention
Number of subjects: 385

Group type: COMPARATOR
Intervention: Comparison between counselor and web-based interventions
Number of subjects: 385
Study: 21491121

Group type: EXPERIMENTAL
Intervention: sCD40L levels in acute PE patients
Number of subjects: 65

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 65
Study: 19527372

Group type: EXPERIMENTAL
Intervention: Offline adaptive radiotherapy using cone beam CT (CBCT)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Online adaptive protocol (theoretical)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Conventional treatment plan
Number of subjects: 5
Study: 18073060

Group type: EXPERIMENTAL
Intervention: Lamivudine monotherapy (100 mg/d)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Lamivudine combined with individualized low-dose HBIG
Number of subjects: 111
Study: 15224086

Group type: EXPERIMENTAL
Intervention: Manual Muscle Test (MMT) for elbow flexion, shoulder flexion, and wrist extension
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Key muscles identified through MMT
Number of subjects: 20
Study: 11145630

Group type: EXPERIMENTAL
Intervention: Intervention group (trained doctors)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (untrained doctors)
Number of subjects: 110
Study: 9530643

Group type: EXPERIMENTAL
Intervention: Enteral diet supplemented with arginine, omega-3 fatty acids, and nucleotides (Impact, Sandoz Nutrition)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (standard enteral diet)
Number of subjects: 32
Study: 8129129

Group type: COMPARATOR
Intervention: Conventional technique with Bain system and tightly-fitting anaesthetic face-mask at 8 l.min-1
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Hudson mask with Bain system at 8 l.min-1
Number of subjects: 10

Group type: COMPARATOR
Intervention: Breathing air
Number of subjects: 10
Study: 2657954

Group type: EXPERIMENTAL
Intervention: General practice antenatal care (not specified dosage or duration)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Smoking status (non-smokers vs smokers)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medication prescribed during pregnancy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sick leave due to low-back pain
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hospitalization due to hypertension and threatened premature labour
Number of subjects: 0
Study: 5307603

Group type: EXPERIMENTAL
Intervention: Acetone-killed agar-grown dried vaccine (vaccine K-66)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heat-killed broth-grown sorbed dried vaccine (vaccine G-66)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other types of typhoid vaccines
Number of subjects: 0

Group type: COMPARATOR
Intervention: Heat-killed broth-grown and acetone-killed agar-grown vaccines
Number of subjects: 0
Study: 29386030

Group type: EXPERIMENTAL
Intervention: Controlled motivation to comply with lifestyle recommendations
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Autonomous motivation
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Motivational internalisation
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Overall motivation for lifestyle change
Number of subjects: 30
Study: 28215058

Group type: EXPERIMENTAL
Intervention: Cervical spinal manipulation (N=28)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Thoracic spinal manipulation (N=30)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (sham-manual contact, N=30)
Number of subjects: 88
Study: 26256065

Group type: EXPERIMENTAL
Intervention: Amlodipine, 5 mg daily; Citalopram, 20 mg daily
Number of subjects: 70

Group type: COMPARATOR
Intervention: Amlodipine, 5 mg daily
Number of subjects: 70
Study: 23146744

Group type: EXPERIMENTAL
Intervention: Spouse-assisted lifestyle intervention (nine monthly goal-setting telephone calls to patients and support planning calls to spouses)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Spouse-assisted lifestyle intervention
Number of subjects: 255

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 255
Study: 22048601

Group type: EXPERIMENTAL
Intervention: Preserved third molar (Group I)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Extracted third molar (Group II)
Number of subjects: 54
Study: 17430467

Group type: EXPERIMENTAL
Intervention: Autologous blood transfusion (ABT)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Allogeneic blood transfusion (HBT)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 35
Study: 15073471

Group type: EXPERIMENTAL
Intervention: Eplerenone 50 mg once daily for 8 weeks
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Eplerenone 100 mg once daily for 8 weeks
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Eplerenone 200 mg once daily for 8 weeks
Number of subjects: 193

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 193
Study: 11932279

Group type: EXPERIMENTAL
Intervention: DHEA supplementation (90 mg orally/d)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 9803690

Group type: EXPERIMENTAL
Intervention: Parenting program intervention
Number of subjects: 394

Group type: COMPARATOR
Intervention: Control condition (regular Head Start program)
Number of subjects: 394
Study: 7640316

Group type: EXPERIMENTAL
Intervention: Small-volume hypocaloric continuous feedings (1 ml/kg/h), beginning at 24 h of age
Number of subjects: 29

Group type: COMPARATOR
Intervention: NPO group (standard intravenous fluid and nutrition, nothing per OS)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 29
Study: 2680286

Group type: EXPERIMENTAL
Intervention: co-dergocrine mesylate (3 mg daily intravenous infusion over 14 days)
Number of subjects: 40

Group type: COMPARATOR
Intervention: placebo (intravenous infusion over 14 days)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: co-dergocrine mesylate
Number of subjects: 40

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 40
Study: 187313

Group type: EXPERIMENTAL
Intervention: Simultaneous treatment with methotrexate, cyclophosphamide, procarbazine, and vincristine
Number of subjects: 118

Group type: COMPARATOR
Intervention: Sequential treatment with methotrexate, cyclophosphamide, procarbazine, and vincristine
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Simultaneous treatment in patients with anaplastic small cell carcinoma
Number of subjects: 118

Group type: COMPARATOR
Intervention: Sequential treatment in patients with anaplastic small cell carcinoma
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Simultaneous treatment in patients with epidermoid carcinoma
Number of subjects: 118

Group type: COMPARATOR
Intervention: Sequential treatment in patients with epidermoid carcinoma
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Maintenance therapy with continued four-drug polychemotherapy
Number of subjects: 118
Study: 30710211

Group type: EXPERIMENTAL
Intervention: Enteral administration of 4.5 g of arginine and 10 g of glutamine per day for 7 days prior to surgery
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard medical care
Number of subjects: 40
Study: 30838883

Group type: EXPERIMENTAL
Intervention: Patient-reported outcomes (PRO) favoring the experimental arm
Number of subjects: 207

Group type: COMPARATOR
Intervention: Clinician-reported adverse events (AEs) favoring the control arm
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Discordance between PROs and AEs
Number of subjects: 207
Study: 28844330

Group type: EXPERIMENTAL
Intervention: Decision Aid (DA)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control
Number of subjects: 129
Study: 25159626

Group type: EXPERIMENTAL
Intervention: VBLaST© trainer (pattern cutting task)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: VBLaST© trainer (ligating loop task)
Number of subjects: 55

Group type: COMPARATOR
Intervention: FLS trainer
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: VBLaST© trainer
Number of subjects: 55
Study: 23276454

Group type: EXPERIMENTAL
Intervention: IMSI
Number of subjects: 75
Study: 21649817

Group type: EXPERIMENTAL
Intervention: Uma Jeunesse®
Number of subjects: 17

Group type: COMPARATOR
Intervention: Juvéderm®
Number of subjects: 17
Study: 19086236

Group type: EXPERIMENTAL
Intervention: Alvimopan 6 mg
Number of subjects: 911

Group type: EXPERIMENTAL
Intervention: Alvimopan 12 mg
Number of subjects: 911

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 911

Group type: EXPERIMENTAL
Intervention: Alvimopan (both doses) in PCA group (n = 317)
Number of subjects: 911

Group type: EXPERIMENTAL
Intervention: Alvimopan (both doses) in non-PCA group (n = 318)
Number of subjects: 911
Study: 16436145

Group type: EXPERIMENTAL
Intervention: White sesame seed extract
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Oleosins (15 and 17 kDa)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Detection tests based on sesame vicillins or other storage proteins
Number of subjects: 32
Study: 15448528

Group type: EXPERIMENTAL
Intervention: Insufflation of humidified carbon dioxide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Insufflation of dry carbon dioxide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no insufflation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Insufflation of dry and humidified air
Number of subjects: 0
Study: 11264626

Group type: EXPERIMENTAL
Intervention: Antenatal education intervention
Number of subjects: 206

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 206
Study: 9829446

Group type: EXPERIMENTAL
Intervention: Azelaic acid 20% cream
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 0
Study: 7853733

Group type: EXPERIMENTAL
Intervention: Carbachol infusion (19 eyes)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Acetylcholine infusion (15 eyes)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Balanced salt solution (BSS) infusion (control, 22 eyes)
Number of subjects: 56
Study: 2780127

Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg methylphenidate
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 1.0 mg/kg methylphenidate
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 12
Study: 3098

Group type: EXPERIMENTAL
Intervention: Cardioselective beta-blockers (practolol, H 87/07, metoprolol)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 54
Study: 30311686

Group type: EXPERIMENTAL
Intervention: Urodynamics
Number of subjects: 41

Group type: COMPARATOR
Intervention: Routine non-invasive tests
Number of subjects: 41
Study: 29216250

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastrojejunostomy (RY)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Billroth-I reconstruction (BI)
Number of subjects: 40
Study: 26140943

Group type: EXPERIMENTAL
Intervention: Reconstituted HDL (rHDL) 40 mg/kg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 23268367

Group type: EXPERIMENTAL
Intervention: 30 mg tabalumab
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 80 mg tabalumab
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Combined tabalumab group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 20961333

Group type: EXPERIMENTAL
Intervention: Glucocorticoid withdrawal (prednisone)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Glucocorticoid continuation (prednisone)
Number of subjects: 0
Study: 19441606

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide aqueous nasal spray (TAA AQ), 110 microg once daily
Number of subjects: 474

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 474
Study: 17195934

Group type: EXPERIMENTAL
Intervention: Vacuum-stabilized orthesis with prescribed full weight bearing after the second week (OG)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Functional aftertreatment with partial weight bearing of 15 kg for 6 weeks (CG)
Number of subjects: 45
Study: 15633326

Group type: COMPARATOR
Intervention: Normal expanded polytetrafluoroethylene (ePTFE) membrane (NM)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Modified ePTFE membrane (MM)
Number of subjects: 10
Study: 11350640

Group type: EXPERIMENTAL
Intervention: Modified cotton gauze (oxidized, sulfonated, phosphorylated)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dialdehyde cotton gauze
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated cotton gauze
Number of subjects: 0
Study: 9393281

Group type: EXPERIMENTAL
Intervention: D2 resection
Number of subjects: 711
Study: 7956499

Group type: EXPERIMENTAL
Intervention: Warm blood cardioplegia (normothermic group)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cold crystalloid (hypothermic group)
Number of subjects: 20
Study: 3652756

Group type: EXPERIMENTAL
Intervention: Pulse oximetry monitoring
Number of subjects: 29

Group type: COMPARATOR
Intervention: Conventional practice with arterial blood gas measurements
Number of subjects: 29
Study: 31351460

Group type: EXPERIMENTAL
Intervention: 5A training
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: ABC training
Number of subjects: 48
Study: 29374382

Group type: EXPERIMENTAL
Intervention: 30 mg/day zinc supplementation
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 27639853

Group type: EXPERIMENTAL
Intervention: Laquinimod (0.6 mg/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 24850280

Group type: EXPERIMENTAL
Intervention: Nicotine patch (10 weeks, double-blind, placebo-controlled)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo (10 weeks, double-blind, placebo-controlled)
Number of subjects: 81
Study: 22236222

Group type: EXPERIMENTAL
Intervention: Subclinical atrial tachyarrhythmias detected by implanted devices (occurring in 261 patients, 10.1%)
Number of subjects: 2580

Group type: EXPERIMENTAL
Intervention: Subclinical atrial tachyarrhythmias detected by implanted devices
Number of subjects: 2580

Group type: COMPARATOR
Intervention: Continuous atrial overdrive pacing
Number of subjects: 2580

Group type: EXPERIMENTAL
Intervention: Subclinical atrial tachyarrhythmias
Number of subjects: 2580
Study: 19283648

Group type: EXPERIMENTAL
Intervention: Psychoeducational group sessions in addition to psychiatric treatment as usual (TAU)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Psychiatric treatment as usual (TAU) without group sessions
Number of subjects: 28